Theres also this recent headline: Which is a touchy subject and I dont want to settle the European regulators investigation (notoriously not overly sensitive about things), but Id venture to say that the psychological impact of obesity and the psychiatric side effects associated with changing body type including dysmorphia and eating disorders probably indicate that this is not a side effect of the drug but rather a side effect of the primary effect of the drug, in a small subset of patients
Descubre lo posible nete a miles de personas que ya han transformado sus experiencias de prdida de peso
(2019) report that GLP-1s may be more effective in treating alcohol use disorder than OUD
doi:10.3390/antiox11010154 Sp N, Kang DY, Kim DH, et al
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30 percent less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Elizabeth McDonald, MD, PhD, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing breast radiologist at Penns Abramson Cancer Center